114
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Associations of Inflammation with Risk of Cardiovascular and All-Cause Mortality in Adults with Hypertension: An Inflammatory Prognostic Scoring System

, ORCID Icon, , , , , , , , , & show all
Pages 6125-6136 | Received 22 Aug 2022, Accepted 22 Oct 2022, Published online: 08 Nov 2022

References

  • Muntner P, Hardy ST, Fine LJ, et al. Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA. 2020;324(12):1190–1200. doi:10.1001/jama.2020.14545
  • Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999–1008. doi:10.1016/S0140-6736(13)61752-3
  • Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549–2558. doi:10.1016/S0140-6736(17)32478-9
  • Hisamatsu T, Segawa H, Kadota A, Ohkubo T, Arima H, Miura K. Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines. Hypertens Res. 2020;43(12):1344–1351. doi:10.1038/s41440-020-0508-z
  • Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982–1004. doi:10.1097/HJH.0000000000002453
  • Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–223. doi:10.1016/S0140-6736(05)17741-1
  • Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens. 2006;15(2):152–158. doi:10.1097/01.mnh.0000203189.57513.76
  • Antonopoulos AS, Angelopoulos A, Papanikolaou P, et al. Biomarkers of vascular inflammation for cardiovascular risk prognostication: a meta-analysis. JACC Cardiovasc Imaging. 2022;15(3):460–471. doi:10.1016/j.jcmg.2021.09.014
  • Jayedi A, Rahimi K, Bautista LE, Nazarzadeh M, Zargar MS, Shab-Bidar S. Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies. Heart. 2019;105(9):686–692. doi:10.1136/heartjnl-2018-314216
  • Li H, Sun K, Zhao R, et al. Inflammatory biomarkers of coronary heart disease. Front Biosci. 2018;10(1):185–196. doi:10.2741/s508
  • Peters SA, Visseren FL, Grobbee DE. Biomarkers. Screening for C-reactive protein in CVD prediction. Nat Rev Cardiol. 2013;10(1):12–14. doi:10.1038/nrcardio.2012.164
  • Mozos I, Jianu D, Gug C, Stoian D. Links between high-sensitivity C-reactive protein and pulse wave analysis in middle-aged patients with hypertension and high normal blood pressure. Dis Markers. 2019;2019:2568069. doi:10.1155/2019/2568069
  • Citu C, Gorun F, Motoc A, et al. The predictive role of NLR, d-NLR, MLR, and SIRI in COVID-19 mortality. Diagnostics. 2022;12(1):122. doi:10.3390/diagnostics12010122
  • Zhang Y, Xing Z, Zhou K, Jiang S. The predictive role of systemic inflammation response index (SIRI) in the prognosis of stroke patients. Clin Interv Aging. 2021;16:1997–2007. doi:10.2147/CIA.S339221
  • Leroux A, Di J, Smirnova E, et al. Organizing and analyzing the activity data in NHANES. Stat Biosci. 2019;11(2):262–287. doi:10.1007/s12561-018-09229-9
  • Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987;77(11):1435–1438. doi:10.2105/ajph.77.11.1435
  • Pate RR, Pratt M, Blair SN, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273(5):402–407. doi:10.1001/jama.273.5.402
  • Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
  • Breiman L. Random Forests. Mach Learn. 2001;45(1):5–32. doi:10.1023/A:1010933404324
  • Mogensen UB, Ishwaran H, Gerds TA. Evaluating random forests for survival analysis using prediction error curves. J Stat Softw. 2012;50(11):1–23. doi:10.18637/jss.v050.i11
  • Pugh D, Dhaun N. Hypertension and vascular inflammation: another piece of the genetic puzzle. Hypertension. 2021;77(1):190–192. doi:10.1161/HYPERTENSIONAHA.120.16420
  • Madhur MS, Elijovich F, Alexander MR, et al. Hypertension: do inflammation and immunity hold the key to solving this epidemic? Circ Res. 2021;128(7):908–933. doi:10.1161/CIRCRESAHA.121.318052
  • Boos CJ, Toon LT, Almahdi H. The relationship between ambulatory arterial stiffness, inflammation, blood pressure dipping and cardiovascular outcomes. BMC Cardiovasc Disord. 2021;21(1):139. doi:10.1186/s12872-021-01946-2
  • Quarck R, Nawrot T, Meyns B, Delcroix M. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;53(14):1211–1218. doi:10.1016/j.jacc.2008.12.038
  • Jackson EK, Cheng D, Ritov VB, Mi Z. Alkaline phosphatase activity is a key determinant of vascular responsiveness to norepinephrine. Hypertension. 2020;76(4):1308–1318. doi:10.1161/HYPERTENSIONAHA.120.15822
  • Shimizu Y, Nakazato M, Sekita T, et al. Association between alkaline phosphatase and hypertension in a rural Japanese population: the Nagasaki Islands study. J Physiol Anthropol. 2013;32(1):10. doi:10.1186/1880-6805-32-10
  • Haarhaus M, Brandenburg V, Kalantar-Zadeh K, Stenvinkel P, Magnusson P. Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. Nat Rev Nephrol. 2017;13(7):429–442. doi:10.1038/nrneph.2017.60
  • Wu Y, Lu C, Pan N, et al. Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases. Sci Rep. 2021;11(1):12997. doi:10.1038/s41598-021-92430-6
  • Cai X, Wang T, Ye C, Xu G, Xie L. Relationship between lactate dehydrogenase and albuminuria in Chinese hypertensive patients. J Clin Hypertens. 2021;23(1):128–136. doi:10.1111/jch.14118
  • Yan H, Vijay A, Jiang F, et al. Serum glucose, lactate dehydrogenase and hypertension are mediators of the effect of body mass index on severity of COVID-19. Endocrinol Diabetes Metab. 2021;4(2):e00215. doi:10.1002/edm2.215
  • Schillaci G, Pirro M, Pucci G, et al. Prognostic value of elevated white blood cell count in hypertension. Am J Hypertens. 2007;20(4):364–369. doi:10.1016/j.amjhyper.2006.10.007
  • Celikbilek A, Ismailogullari S, Zararsiz G. Neutrophil to lymphocyte ratio predicts poor prognosis in ischemic cerebrovascular disease. J Clin Lab Anal. 2014;28(1):27–31. doi:10.1002/jcla.21639
  • Siedlinski M, Jozefczuk E, Xu X, et al. White blood cells and blood pressure: a Mendelian randomization study. Circulation. 2020;141(16):1307–1317. doi:10.1161/CIRCULATIONAHA.119.045102
  • Skrzypczyk P, Przychodzień J, Bombińska M, Kaczmarska Z, Mazur M, Pańczyk-Tomaszewska M. Complete blood count-derived inflammatory markers in adolescents with primary arterial hypertension: a preliminary report. Cent Eur J Immunol. 2018;43(4):434–441. doi:10.5114/ceji.2018.81353
  • Haas ME, Aragam KG, Emdin CA, et al. Genetic association of albuminuria with cardiometabolic disease and blood pressure. Am J Hum Genet. 2018;103(4):461–473. doi:10.1016/j.ajhg.2018.08.004
  • Lappé JM, Horne BD, Shah SH, et al. Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. Clin Chim Acta. 2011;412(23–24):2094–2099. doi:10.1016/j.cca.2011.07.018
  • Ozcan F, Turak O, Durak A, et al. Red cell distribution width and inflammation in patients with non-dipper hypertension. Blood Press. 2013;22(2):80–85. doi:10.3109/08037051.2012.707336
  • Davidson SM, Andreadou I, Barile L, et al. Circulating blood cells and extracellular vesicles in acute cardioprotection. Cardiovasc Res. 2019;115(7):1156–1166. doi:10.1093/cvr/cvy314
  • Haybar H, Pezeshki SMS, Saki N. Evaluation of complete blood count parameters in cardiovascular diseases: an early indicator of prognosis? Exp Mol Pathol. 2019;110:104267. doi:10.1016/j.yexmp.2019.104267
  • Balan R, Bălăşescu E, Ion DA. Inflammation and arterial hypertension-pathophysiological links and clinical aspects. Curr Health Sci J. 2020;46(4):383–389. doi:10.12865/CHSJ.46.04.09
  • Rather RA, Dhawan V. Genetic markers: potential candidates for cardiovascular disease. Int J Cardiol. 2016;220:914–923. doi:10.1016/j.ijcard.2016.06.251
  • Holewijn S, den Heijer M, Kiemeney LA, Stalenhoef AF, de Graaf J. Combining risk markers improves cardiovascular risk prediction in women. Clin Sci. 2014;126(2):139–146. doi:10.1042/CS20130178
  • Ambale-Venkatesh B, Yang X, Wu CO, et al. Cardiovascular event prediction by machine learning: the multi-ethnic study of atherosclerosis. Circ Res. 2017;121(9):1092–1101. doi:10.1161/CIRCRESAHA.117.311312